IP Library Granted Patent US 9,598,501
Granted Patent B2
US 9,598,501 · App. 14/502,013 · Granted Mar 21, 2017

Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier

Inventors: Yoichi Kumada (Kyoto, JP); Michimasa Kishimoto (Kyoto, JP); Kyoko Hamasaki (Kyoto, JP); Aya Nakagawa (Kyoto, JP)
Assignees: NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY; DENKA SEIKEN CO., LTD
C07K17/00C07K16/00C07K16/18C07K16/249C07K16/2887C07K16/303C07K16/40C07K2317/21C07K2317/24C07K2317/51C07K2317/515C07K2317/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,598,501
App. No.
14/502,013
Granted
Mar 21, 2017
Kind
B2
Abstract

The present invention provides an antibody-immobilized carrier that can be used in antibody screening, a method of producing the antibody-immobilized carrier, and use of the antibody-immobilized carrier. Efficient antibody screening can be carried out particularly by an antibody-immobilized carrier including two or more antibody immobilized regions onto each of which a heavy-chain low-molecular-weight antibody and a light-chain low-molecular-weight antibody are separately immobilized, the two or more antibody immobilized regions each being included in an independent manner, the heavy-chain low-molecular-weight antibody including a heavy-chain variable region, the light-chain low-molecular-weight antibody including a light-chain variable region, the heavy-chain low-molecular-weight antibody and the light-chain low-molecular-weight antibody each being derived from an antibody recognizing a different antigen.

Claims (16)

1. A method of producing an antibody-immobilized carrier surface, comprising:

immobilizing one or more heavy-chain low-molecular-weight antibody fragments comprising a heavy-chain variable region (VH) fused to the N-terminus of a carrier binding peptide wherein the carrier binding peptide is selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19; and

immobilizing one or more light-chain low-molecular-weight antibody fragments comprising a light-chain variable region (VL) fused to the N-terminus of a carrier binding peptide wherein the carrier binding peptide is selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19 sequentially onto a carrier surface, wherein the material of the carrier surface is selected from the group consisting of a polystyrene plastic resin, a polycarbonate plastic resin, a polymethyl methacrylate plastic resin, a plastic resin obtained through hydrophilizing a polystyrene plastic resin, a plastic resin obtained through hydrophilizing a polycarbonate plastic resin, and a plastic resin obtained through hydrophilizing a polymethyl methacrylate plastic resin,

so that an antibody immobilized carrier surface is prepared.

2. The method as set forth in claim 1 , wherein the steps of immobilizing is repeated at least two times.

3. The method as set forth in claim 1 , wherein the step of immobilizing comprising:

(a) denaturing insoluble aggregates of said heavy-chain low-molecular-weight antibody fragments and said light-chain low-molecular-weight antibody fragments with a denaturing agent prior to said immobilizing; and

(b) refolding said denatured heavy-chain low-molecular-weight antibody fragments and said denatured light-chain low-molecular-weight antibody fragments, by removing the denaturing agent from said immobilized low-molecular-weight antibody fragments.

4. The method as set forth in claim 3 , wherein steps (a) and (b) are carried out separately for each of the heavy-chain low-molecular-weight antibody fragments and the light-chain low-molecular-weight antibody fragments.

5. The method as set forth in claim 4 , wherein

steps (a) and (b) are carried out for the light-chain low-molecular-weight antibody fragment prior to the heavy-chain low-molecular-weight antibody fragments.

6. The method as set forth in claim 3 , wherein

the denaturing agent is urea at a concentration range of 0.5 M to 4 M.

7. An antibody-immobilized carrier surface obtained by the method as set forth in claim 2 .

8. The method as set forth in claim 1 , wherein:

the heavy-chain low-molecular-weight antibody fragment and the light-chain low-molecular-weight antibody fragment are each being from an antibody recognizing a different antigen.

Assignments (3)
CHANGE OF NAME Recorded Jul 21, 2020
From: DENKA SEIKEN CO., LTD
To: DENKA COMPANY LIMITED
Reel/Frame 053270/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2014
From: KUMADA, YOICHI; KISHIMOTO, MICHIMASA; HAMASAKI, KYOKO; NAKAGAWA, AYA
To: NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY
Reel/Frame 033854/0464 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2014
From: NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY
To: NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY; DENKA SEIKEN CO., LTD
Reel/Frame 033855/0562 →
Priority Claims (1)
JP 2010-031684 · Feb 16, 2010 · national
Continuity (2)
Division 13578974
Related Publication 20150018534A1 · Jan 15, 2015